Archive ready

一般財団法人化学及血清療法研究所が製造販売する乾燥細胞培養日本脳炎ワクチンについて|厚生労働省

https://www.mhlw.go.jp/stf/houdou/0000113746.html
April 7, 2026 at 03:00 AM JSTThe archive page, viewer, and downloads use this saved version.
April 7, 2026 at 03:00 AM JST·www.mhlw.go.jp

The evidence pack includes HTML, screenshots, summaries, and metadata. It can be downloaded on Pro.

Saved page

一般財団法人化学及血清療法研究所が製造販売する乾燥細胞培養日本脳炎ワクチンについて|厚生労働省

Open the archived HTML with saved-time metadata attached.

StartedApril 7, 2026 at 03:00 AM JST

This HTML has CSS and images embedded, so it can still be opened even if the original page disappears.

About this pageAI generated

This page announces the Ministry of Health, Labour and Welfare's decision regarding the dried cell culture Japanese encephalitis vaccine "Ensebach" manufactured by the Institute for Protein Research. The institute's products had discrepancies between approval documents and manufacturing practices, leading to a shipment suspension request in September 2015. Following review by the Infectious Diseases Division of the Health Science Council, the ministry determined no serious quality or safety issues existed. On February 26, 2016, the shipment suspension was lifted to prevent supply shortages and support Japanese encephalitis prevention efforts.

一般財団法人化学及血清療法研究所が製造販売する乾燥細胞培養日本脳炎ワクチンについて|厚生労働省 - Saved screenshot

The full page can be captured up to 15,000px in height so you can review the complete page layout when needed.